机译:招募22,000名青春期妇女参加癌症登记册随访,以获取长期人类乳头瘤病毒疫苗功效:避免猜测
University of Tampere, Tampere, Finland;
National Public Health Institute, Oulu, Finland;
Family Federation of Finland, Helsinki and Oulu, Finland;
GSK Biologicals, King of Prussia, PA, USA;
University of Tampere, Tampere, Finland;
Family Federation of Finland, Helsinki and Oulu, Finland;
Municipal Health Center of Mikkeli, Mikkeli, Finland;
University of Tampere, Tampere, Finland;
Municipal Health Center of Turku, Turku, Finland;
Finnish Cancer Registry, Helsinki, Finland;
Municipal Health Center of Kotka, Kotka, Finland;
University of Kuopio, Kuopio, Finland;
University of Tampere, Tampere, Finland;
Municipal Health Center of Lahti, Lahti, Finland;
University of Tampere, Tampere, Finland;
University of Tampere, Tampere, Finland;
University of Tampere, Tampere, Finland;
Family Federation of Finland, Helsinki and Oulu, Finland;
University of Tampere, Tampere, Finland;
Finnish Cancer Registry, Helsinki, Finland;
Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland;
CERVICAL CANCER • HERD IMMUNITY • PREVENTION • VACCINATION;
机译:招募22,000名青春期妇女参加癌症登记处随访,以获取长期的人类乳头瘤病毒疫苗功效:防止猜测。
机译:人类乳头瘤病毒疫苗有效性的长期随访试验中的青少年人群研究
机译:在人乳头瘤病毒疫苗效力的长期随访研究中,青少年为基础的青少年入组。
机译:合奏特征为评估宫颈癌检测试验和人乳头瘤病毒基因型在检测高级宫颈上皮内瘤和宫颈癌中的疗效进行评估框架
机译:人乳头瘤病毒16型疫苗的长期疗效。
机译:人乳头瘤病毒疫苗针对最严格的宫颈赘生物终点的十年随访-基于登记的随机试验的三个队列的随访
机译:对人乳头瘤病毒疫苗针对最严格的宫颈赘生物终点的十年随访-基于登记的对来自随机试验的三个队列的随访